We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
- Authors
Sherman, Amy C; Desjardins, Michaël; Cheng, Chi An; Bausk, Bruce; Izaguirre, Natalie; Zhou, Guohai; Krauss, Jonathan; Tolan, Nicole; Walt, David R; Soiffer, Robert; Ho, Vincent T; Issa, Nicolas C; Baden, Lindsey R
- Abstract
The severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine–induced humoral response and reactogenicity profile are described in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Findings showed that 75.0% (by Simoa assay) or 80.0% (by Roche assay) of the HSCT cohort had a positive antibody response on series completion, compared with 100% in the healthy cohort.
- Subjects
COVID-19 vaccines; SERODIAGNOSIS; PATIENTS; TREATMENT effectiveness; MESSENGER RNA; DESCRIPTIVE statistics; HEMATOPOIETIC stem cell transplantation; TRANSPLANTATION of organs, tissues, etc.
- Publication
Clinical Infectious Diseases, 2022, Vol 75, Issue 1, pe920
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciab930